Dr Lisa Holland
Contact information
Lisa Holland
PhD
Research Facilitator
Lisa is Research Facilitator for the Mexico City Prospective Study – a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
She joined the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2006 as a member of the Vascular Overviews Group. Lisa worked on the meta-analyses of clinical trials of statins (Cholesterol Treatment Trialists Collaboration), of non-steroidal anti-inflammatory drugs (Coxib and NSAID Trialists Collaboration), and of angiotension receptor blockers for the treatment of Marfan Syndrom.
Lisa Holland completed an undergraduate degree in Biochemistry with Microbiology at Lancaster University and a PhD in Molecular Microbiology at the University of Nottingham.